Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 3
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
[Results of the Russian EKSPERT program: post-marketing supervision over efficacy and influence of the preparation Ekvator on quality of life at out-patients with arterial hypertension].
Glezer MG, Vygodin VA, Avakian AA, Prokof'eva EB. Glezer MG, et al. Kardiologiia. 2014;54(3):15-22. doi: 10.18565/cardio.2014.3.15-22. Kardiologiia. 2014. PMID: 25102744 Russian.
Results of an open multicenter prospective postmarketing observational program EKSPERT (post-marketing surveillance of the effectiveness and impact of the EKVATOR treatment on quality of life in patients with arterial hypertension in ambulatory practice). ...Replacing the …
Results of an open multicenter prospective postmarketing observational program EKSPERT (post-marketing surveillance of the effectiveness and …
ANICHKOV study: the effect of combined hypotensive and lipid-lowering therapy on cardiovascular complications in patients of high and very high risk.
Sergienko IV, Ansheles AA, Drapkina ОМ, Gornyakova NB, Zubareva MY, Shepel RN, Kuharchuk VV, Boytsov SA. Sergienko IV, et al. Ter Arkh. 2019 May 16;91(4):90-98. doi: 10.26442/00403660.2019.04.000104. Ter Arkh. 2019. PMID: 31094482 Clinical Trial.
When history of AH existed or AH detected at visit I, patients were randomized to scheme II (Ekvamer 5/10/10 mg/day) or III (Mertenil 10 mg/day + Ekvator 5/10 mg/day). During the observation, the treatment scheme remained unchanged, however, if the target levels of LDL-C a …
When history of AH existed or AH detected at visit I, patients were randomized to scheme II (Ekvamer 5/10/10 mg/day) or III (Mertenil 10 mg/ …
[Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].
Statsenko ME, Derevianchenko MV. Statsenko ME, et al. Ter Arkh. 2014;86(8):90-3. Ter Arkh. 2014. PMID: 25306751 Clinical Trial. Russian.
AIM: To evaluate the impact of 6-month antihypertensive therapy with the combined drug amlodipine + lisinopril (ekvator) on endothelial dysfunction (ED) and carbohydrate metabolic parameters in patients with hypertension and type 2 diabetes mellitus (DM). ...
AIM: To evaluate the impact of 6-month antihypertensive therapy with the combined drug amlodipine + lisinopril (ekvator) on endotheli …
[Impact of combination antihypertensive therapy on heart rate variability parameters and target organ status in patients with arterial hypertension and type 2 diabetes mellitus].
Statsenko ME, Derevianchenko MV, Titarenko MN, Mihaleva AV. Statsenko ME, et al. Ter Arkh. 2013;85(12):21-6. Ter Arkh. 2013. PMID: 24640663 Clinical Trial. Russian.
AIM: To evaluate the impact of combination antihypertensive therapy with ekvator on heart rate variability (HRV) parameters and target organ status in patients with arterial hypertension (AH) and type 2 diabetes mellitus (T2DM). ...Echocardiography was performed and arteri …
AIM: To evaluate the impact of combination antihypertensive therapy with ekvator on heart rate variability (HRV) parameters and targe …
[Endothelial dysfunction is a target for combination antihypertensive therapy in hypertensive patients with type 2 diabetes mellitus].
Statsenko ME, Derevianchenko MV, Ostrovskiĭ OV, Titarenko MN, Shvets MK, Bondarev AM. Statsenko ME, et al. Ter Arkh. 2013;85(9):63-8. Ter Arkh. 2013. PMID: 24261232 Clinical Trial. Russian.
AIM: To evaluate the impact of combination antihypertensive therapy with lisinopril + amlodipine (Ekvator) on endothelial dysfunction in patients with hypertension and concurrent type 2 diabetes mellitus (T2DM). ...CONCLUSION: Twelve-week treatment with the combined antihy …
AIM: To evaluate the impact of combination antihypertensive therapy with lisinopril + amlodipine (Ekvator) on endothelial dysfunction …
[A fixed-dose lisinopril and amlodipine combination in conjunction with rosuvastatin in patients with hypertensive disease and coronary heart disease].
Galeeva ZM, Galiavich AS. Galeeva ZM, et al. Ter Arkh. 2014;86(9):71-6. Ter Arkh. 2014. PMID: 25518509 Clinical Trial. Russian.
AIM: To evaluate the efficacy and safety of a fixed-dose combination of the angiotensin-converting enzyme inhibitor lisinopril 10 mg and the calcium antagonist amlodipine 5 mg (ekvator) in conjunction with rosuvastatin (mertenil). SUBJECTS AND METHODS: The investigation en …
AIM: To evaluate the efficacy and safety of a fixed-dose combination of the angiotensin-converting enzyme inhibitor lisinopril 10 mg and the …